| Dr Jim K Lai, MD | |
|
10 N Greene St, Baltimore, MD 21201-1524 | |
| (410) 605-7000 | |
| Not Available |
| Full Name | Dr Jim K Lai |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 10 N Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164859484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | D89128 (Maryland) | Primary |
| 208D00000X | General Practice | D89128 (Maryland) | Secondary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191003001442 |
News Archive
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) today launched a "parallel review" pilot program for concurrent review of medical devices for FDA approval and Medicare coverage.
While Wisconsin Gov. Scott Walker faces a dilemma regarding his state's Early Innovator Grant, South Dakota Gov. Dennis Daugaard announced his state wouldn't try to pass health exchange legislation because "there is too much uncertainty."
Advanced Life Sciences Holdings, Inc. has announced the submission of a new drug application (NDA) for cethromycin in mild-to-moderate community acquired pneumonia (CAP). Advanced Life Sciences also entered into debt and equity financing agreements to strengthen its balance sheet and help fund commitments associated with the NDA submission and pre-commercialization activities.
Gov. C.L. 'Butch' Otter removed a political abscess Tuesday, restoring all previously contracted dental care providers to the state's Medicaid-funded Idaho Smiles program.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jim K Lai, MD 10 N Greene St, Surgical Services 5c-117, Baltimore, MD 21201-1524 Ph: (410) 605-7000 | Dr Jim K Lai, MD 10 N Greene St, Baltimore, MD 21201-1524 Ph: (410) 605-7000 |
News Archive
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) today launched a "parallel review" pilot program for concurrent review of medical devices for FDA approval and Medicare coverage.
While Wisconsin Gov. Scott Walker faces a dilemma regarding his state's Early Innovator Grant, South Dakota Gov. Dennis Daugaard announced his state wouldn't try to pass health exchange legislation because "there is too much uncertainty."
Advanced Life Sciences Holdings, Inc. has announced the submission of a new drug application (NDA) for cethromycin in mild-to-moderate community acquired pneumonia (CAP). Advanced Life Sciences also entered into debt and equity financing agreements to strengthen its balance sheet and help fund commitments associated with the NDA submission and pre-commercialization activities.
Gov. C.L. 'Butch' Otter removed a political abscess Tuesday, restoring all previously contracted dental care providers to the state's Medicaid-funded Idaho Smiles program.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
› Verified 3 days ago
Robert S Mayer, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-532-4701 | |
Nia C Wallace Ward, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Kennedy Krieger Institute, Baltimore, MD 21205 Phone: 443-923-9200 Fax: 443-923-9405 | |
Susan Miller, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7500 Security Blvd, Mailstop: C1-09-06, Baltimore, MD 21244 Phone: 410-786-2118 | |
Christine Yunjae Wang, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-9000 | |
Jason P Brokaw, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2700 Quarry Lake Drive, Suite 300, Baltimore, MD 21209 Phone: 410-377-8900 Fax: 410-377-3156 | |
Pablo Ariel Celnik, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-532-4701 | |
Behnam Jafarpour, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3421 Benson Ave, Suite 210, Baltimore, MD 21227 Phone: 443-693-7246 |